Can an Algorithm Find What Your Body Actually Needs? Introducing SEMO for Longevity Technology

DeepoMe’s SEMO is a pre-trained network-medicine framework that connects individual omics signals to compound target networks.

It aims to generate personalized biomarkers, drug targets, and intervention ideas instead of one-size-fits-all longevity advice.

The approach uses human protein-protein interaction networks and compound-target relationships to infer biologically relevant gaps.

The article also points to a granted Chinese patent, CN117766054B, and a related bioRxiv preprint describing the method.